Substitute for Raised S.B. No. 186
Session Year 2022
 

AN ACT CONCERNING COLLABORATIVE DRUG THERAPY MANAGEMENT AGREEMENTS AND POLICIES.

To: (1) Enable care-giving institutions to institute, and certain pharmacists to operate under, collaborative drug therapy management policies; (2) provide that prescribing practitioners and pharmacists may enter into collaborative drug therapy management agreements and operate under collaborative drug therapy management policies; (3) provide that collaborative drug therapy management agreements and policies may apply to patient populations; (4) require that written protocols and collaborative drug therapy care plans (A) be specific to the patient, patients or patient populations involved, (B) contain detailed direction concerning the actions pharmacists may perform for the patient population involved, (C) include the therapeutic class of drug or classes of drugs, or medical devices, to be managed by pharmacists, and (D) contain a definition of the patient population involved; (5) eliminate a reporting requirement concerning encounters within the scope of collaborative drug therapy management agreements; (6) impose a reporting requirement concerning changes made to drug therapies within the scope of collaborative drug therapy management agreements and policies; and (7) require the Commissioner of Consumer Protection to adopt regulations concerning collaborative drug therapy management policies.

Introduced by: